Prostate Cancer

FDA Approves New Prostate Cancer Imaging Agent Gozellix® March 21, 2025

Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort. March 21, 2025

Real-world treatment patterns and genetic testing in a metastatic castration-resistant prostate cancer setting in Europe. March 21, 2025

A simplified MyProstateScore2.0 for high-grade prostate cancer. March 21, 2025

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. March 21, 2025

Predictive Model of Acute Rectal Toxicity in Prostate Cancer Treated With Radiotherapy. March 21, 2025

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST). March 20, 2025

Risk-stratified Approach to Implementing Population-based Prostate Cancer Screening in Five Pilot Sites in the European Union: A Protocol for the PRAISE-U Project. March 20, 2025

Apalutamide use in metastatic hormone-sensitive prostate cancer patients diagnosed by conventional and next-generation imaging. Real world data from 772 patients. March 20, 2025

Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. March 20, 2025

Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience. March 20, 2025

Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy. March 20, 2025

"Hope at a better chance": perspectives on genetic counseling and testing among black individuals with prostate cancer. March 19, 2025

Low incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center. March 19, 2025

Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study. March 19, 2025

Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysis. March 19, 2025

The Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making. March 19, 2025

Incidence of prostate cancer in men with testosterone deficiency and a family history of prostate cancer receiving testosterone therapy: a comparative study. March 19, 2025

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center March 18, 2025

Principles of optimal multidisciplinary management of prostate cancer in clinical practice. March 18, 2025

Page 1 of 1466